The Florida Department of Health is accepting applications for its 2024-2025 Live Like Bella Pediatric Cancer Research Initiative Grant Program.
Donor Name: Florida Department of Health
State: Florida
County: All Counties
Type of Grant: Grant
Deadline: (mm/dd/yyyy) 08/29/2024
Size of the Grant: $100,000 to $500,000
Grant Duration: 4 Years
Details:
The Live Like Bella Pediatric Cancer Research Initiative (Bella Initiative) is established in section 381.922, Florida Statutes. The Florida Legislature specified the purpose of the Initiative is to advance progress toward curing pediatric cancer through grants awarded through a peer-reviewed, competitive process. The Bella Initiative will provide grants for research to further the search for cures for pediatric cancer, by pursuing the following goals: 

Significantly expand pediatric cancer research capacity in Florida. 
Improve both research and treatment through greater pediatric enrollment in clinical trials networks.
Reduce the impact of pediatric cancer on disproportionately impacted individuals.

Research Priorities

The Biomedical Research Advisory Council (BRAC) advises the State Surgeon General as to the direction and scope of grant programs. The responsibilities of the council may include, but are not limited to:

Providing advice on Program priorities and emphases.
Developing criteria and standards for the award of research grants.

To balance the number of grants awarded across Research Priorities, this year the Department will prioritize applications that address the following:

Reduction of mortality and morbidity as related to disproportionately impacted individuals.
Improve screening accuracy and detection in high-risk groups.
Resistance to front-line treatments in recurrent disease in the five cancers listed.
Research focused on sarcomas, or leukemia and other blood cancers.
Prevention and treatment research evaluating programs for tobacco use reduction and prevention (James & Esther King Program).
Research focused on the biologic mechanisms of use of electronic cigarettes, transition from combustible tobacco to electronic cigarettes, relationship between electronic cigarette use and different cancers, effects of electronic cigarette use in individuals treated for cancer, and intervention to reduce or prevent electronic cigarette use. (James and Esther King Program).
Examine the relationship between obesity and cancer, cancer treatment responsiveness, and cancer treatment-related morbidities. Applications related to other areas described in the FOA will be considered, but not at the same level of priority.

Funding Information
The following types of grants are available to pursue the above seven research priorities. Applications for Research Infrastructure grants that are reviewed and assigned exceptional scientific merit will be considered for preferential funding.

Grant Mechanism: Multicenter Clinical Trials

Maximum Amount (Including direct and indirect costs): $900,000
Maximum Duration: 48 Months

Grant Mechanism: High-Risk, High-Reward Clinical Trials

Maximum Amount (Including direct and indirect costs): $300,000
Maximum Duration: 48 Months

Grant Mechanism: Discovery Science

Maximum Amount (Including direct and indirect costs): $250,000 
Maximum Duration: 36 Months

Grant Mechanism: High-Risk, High-Reward Discovery Science

Maximum Amount (Including direct and indirect costs): $125,000
Maximum Duration: 36 Months

Grant Mechanism: Bridge

Maximum Amount (Including direct and indirect costs): $100,000
Maximum Duration: 6 months

Grant Mechanism: Equipment

Maximum Amount (Including direct and indirect costs): $100,000
Maximum Duration: 12 months

Grant Mechanism: Non-typical Clinical Trials/Socio-behavioral Research

Maximum Amount (Including direct and indirect costs): $250,000
Maximum Duration: 36 months

Grant Mechanism: New Investigator Research (NIR)

Maximum Amount (Including direct and indirect costs): $300,000
Maximum Duration: 36 months.

Eligibility Criteria

According to sections 215.5602(5) (a) and 381.922(3) (a), Florida Statutes, applications for biomedical research funding may be submitted from any university or established research institute in Florida.
Each application must identify a Corresponding Principal Investigator. The Corresponding Principal Investigator is the individual designated by the applicant organization legally responsible to direct the grant project. The Corresponding Principal Investigator is responsible and accountable to the applicant organization officials for the project’s scientific and technical direction as well as the proper conduct of the project. There must be one designated Corresponding Principal Investigator. There may be multiple Principal Investigators on a project, but there must be only one Corresponding Principal Investigator.

For more information, visit DOH.